With the exception of clonally dominant mutations in TP53, TNBCs demonstrate a high degree of inter-tumor and intra-tumor heterogeneity at the mutational level with each driver mutation only present in a subset of tumors and clones within any individual tumor9. The gene discussed is TP53; the disease is neoplasm.